Prognostic factors in non-seminomatous germ cell tumours of the testis. Experience at the Institut Gustave-Roussy

Eur Urol. 1993;23(1):188-95. doi: 10.1159/000474592.

Abstract

The original prognostic model in non-seminomatous germ cell tumours of the testis at the Institut Gustave-Roussy was updated in a larger patient population. As in the former model human chorionic gonadotrophin (hCG) and alpha-feto-protein (AFP) serum concentrations attained prognostic significance in the multivariate analysis. We studied two important issues in this patient population: the impact of expressing hCG values in mass units and of the introduction of etoposide-containing chemotherapy. Etoposide has a major impact on the determination of the prognostic group limits which are considerably increased. It is, thus, suggested to reevaluate prognostic models in patient populations treated by modern chemotherapy regimens.

Publication types

  • Review

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Chorionic Gonadotropin / blood
  • Combined Modality Therapy
  • Humans
  • Male
  • Models, Biological
  • Neoplasms, Germ Cell and Embryonal / secondary
  • Neoplasms, Germ Cell and Embryonal / therapy*
  • Prognosis
  • Remission Induction
  • Survival Rate
  • Testicular Neoplasms / pathology
  • Testicular Neoplasms / therapy*

Substances

  • Chorionic Gonadotropin